Form 4: Ekso Bionics CFO Jerome Wong Reports Acquisition of Shares Through 401(k) Contribution
SEC Form 4 Filing
Chief Financial Officer Jerome Wong reports acquiring 24,248 shares of Ekso Bionics Holdings, Inc. common stock through the company's 401(k) contribution matching program.
Summary
- On March 14, 2025, Jerome Wong, the Chief Financial Officer of Ekso Bionics Holdings, Inc., acquired 24,248 shares of common stock.
- These shares were obtained through the Issuer's 401(k) contribution matching program.
- Following this transaction, Wong directly owns 266,953 shares and indirectly owns 43,135 shares through a 401(k).
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock ownership, and doesn't convey any particular positive or negative sentiment.
Positives
- The acquisition of shares through the 401(k) program aligns the CFO's interests with those of the company and its shareholders.
Industry Context
This filing is a routine disclosure related to executive compensation and holdings, and doesn't necessarily reflect a significant event for Ekso Bionics or the broader industry.
Stakeholder Impact
- The transaction has a minor positive impact on stakeholders by aligning management's interests with shareholders through increased stock ownership.
Key Dates
| Date | Description |
|---|---|
| 03/14/2025 | Date of transaction: Jerome Wong acquired shares of common stock through the 401(k) contribution matching program. |
| 03/18/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.